Rating: Strong Buy
Amgen Financial Health
Profitability:9.34/10
✅ Amgen has better Profitability than 73.68% of the companies on the Biotechnology industry
Net Margin: 32.9%
✅ Amgen has better Net Margin than 66.67% of the companies on the Biotechnology industry
ROE (Return on Equity): 18.77%
✅ Amgen has better ROE (Return on Equity) than 94.12% of the companies on the Biotechnology industry
ROA (Return on Assets): 3.14%
✅ Amgen has better ROA (Return on Assets) than 61.11% of the companies on the Biotechnology industry
Operating Efficiency:9.5/10
✅ Amgen has better Operating Efficiency than 76.47% of the companies on the Biotechnology industry
Operating Margin: 40.97%
✅ Amgen has better Operating Margin than 76.47% of the companies on the Biotechnology industry
Liquidity:6.14/10
❌ Amgen has worst Liquidity than 100% of the companies on the Biotechnology industry
Quick Ratio: 1.28
❌ Amgen has worst Quick Ratio than 100% of the companies on the Biotechnology industry
Operating Cash Flow Ratio: 0.74
✅ Amgen has better Operating Cash Flow Ratio than 55.56% of the companies on the Biotechnology industry
Solvency:0.91/10
❌ Amgen has worst Solvency than 94.44% of the companies on the Biotechnology industry
Debt to Equity Ratio: 3.36
❌ Amgen has worst Debt to Equity Ratio than 94.12% of the companies on the Biotechnology industry
Interest Coverage Ratio: 0.74
✅ Amgen has better Interest Coverage Ratio than 55.56% of the companies on the Biotechnology industry